Search

Your search keyword '"Laborde-Casterot H"' showing total 4 results
Start Over Author "Laborde-Casterot H" Search Limiters Full Text
4 results on '"Laborde-Casterot H"'

1. Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study

Author

Matrat, M. (Mireille), Gain, M. (Murielle), Haioun, C. (Corinne), Le Bras, F. (Fabien), Nisse, C. (Catherine), Morschhauser, F. (Franck), Clin, B. (Benedicte), Baldi, I. (Isabelle), Verdun-Esquer, C. (Catherine), Garnier, R. (Robert), Laborde-Casterot, H. (Herve), Herin, F. (Fabrice), Esquirol, Y. (Yolande), Andujar, P. (Pascal), Belacel, M. (Milia), Chouaid, C. (Christos), Chauvet, C. (Claire), Lasfargues, G. (Gerard), Pairon, J-C. (Jean-Claude), Pairon, CHU Lille, Institut Pasteur de Lille, Université de Lille, Centre Hospitalier Intercommunal de Créteil [CHIC], IMPact de l'Environnement Chimique sur la Santé humaine (IMPECS) - ULR 4483, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365, Hôpital Henri Mondor, Institut Mondor de Recherche Biomédicale [IMRB], Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers [ANTICIPE], Bordeaux population health [BPH], Hôpital Lariboisière-Fernand-Widal [APHP], Institut Mondor de recherche biomédicale [IMRB], Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail [ANSES], CHI Créteil, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Impact de l'environnement chimique sur la santé humaine - ULR 4483 (IMPECS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers (ANTICIPE), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER-Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut Santé-Travail Paris-Est [Créteil], Université Paris-Est Créteil, Faculté de Médecine [Créteil] (UPEC-Médecine), Centre de Recherche Clinique [Créteil] (CRC), Centre Hospitalier Intercommunal de Créteil (CHIC), IMRB - CEPIA/'Clinical Epidemiology And Ageing : Geriatrics, Primary Care and Public Health' [Créteil] (U955 Inserm - UPEC), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Direction des alertes et des vigilances sanitaires (DAVS), Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES), Anses (2015-CRD-29, 2018-CRD-20), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER, CHU Toulouse [Toulouse], and Admin, Oskar

Subjects
[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematology, Male, Health, Toxicology and Mutagenesis, Chronic lymphocytic leukemia, lcsh:Medicine, Disease, 0302 clinical medicine, immune system diseases, Risk Factors, hemic and lymphatic diseases, Surveys and Questionnaires, Non-Hodgkin lymphoma, Occupational disease, Exposure to solvents, Exposure to pesticides, Workers’ compensation, Multiple myeloma, Lymphoma, Non-Hodgkin, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Middle Aged, 030210 environmental & occupational health, 3. Good health, Occupational Diseases, 030220 oncology & carcinogenesis, medicine.medical_specialty, Workers' compensation, [SDV.CAN]Life Sciences [q-bio]/Cancer, Article, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, Occupational Exposure, medicine, [SDV.EE.SANT] Life Sciences [q-bio]/Ecology, environment/Health, Humans, In patient, [SDV.EE.SANT]Life Sciences [q-bio]/Ecology, environment/Health, business.industry, lcsh:R, Public Health, Environmental and Occupational Health, medicine.disease, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Case-Control Studies, Hodgkin lymphoma, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business
Abstract

Non-Hodgkin lymphoma (NHL), multiple myeloma and chronic lymphocytic leukemia are possibly related to environmental and/or occupational exposure. The primary objective of this study was to develop a questionnaire for screening patients with these blood disorders who might benefit from a specialized consultation for possible recognition of the disease as an occupational disease. The study included 205 subjects (male gender, 67.3%, mean age, 60 years, NHL, 78.5%). The questionnaire performed very satisfactorily in identifying the exposures most frequently retained by experts for their potential involvement in the occurrence of NHL. Its sensitivity and specificity in relation to the final expertise were 96% and 96% for trichloroethylene, 85% and 82% for benzene, 78% and 87% for solvents other than trichloroethylene and dichloromethane, 87% and 95% for pesticides, respectively. Overall, 15% of the subjects were invited to ask National Social Insurance for compensation as occupational disease. These declarations concerned exposure to pesticides (64%), solvents (trichloroethylene: 29%, benzene: 18%, other than chlorinated solvents: 18%) and sometimes multiple exposures. In conclusion, this questionnaire appears as a useful tool to identify NHL patients for a specialized consultation, in order to ask for compensation for occupational disease.

Published
2021
Full Text
View/download PDF

2. Efficacité d’une prise en charge médicamenteuse conforme aux recommandations à la sortie de l’hôpital sur la mortalité chez les patients en insuffisance cardiaque à fraction d’éjection abaissée en conditions de pratique courante

Author

Busson, A., primary, Laborde-Casterot, H., additional, Alla, F., additional, Messikh, Z., additional, Clerc-Urmes, I., additional, Mebazaa, A., additional, Thilly, N., additional, and Agrinier, N., additional

Published
2017
Full Text
View/download PDF

4. Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study.

Author

Benarous L, Terrier B, Laborde-Casterot H, Bérezné A, Dunogué B, Cohen P, Puéchal X, Mouthon L, Bensefa-Colas L, and Guillevin L

Subjects
Aged, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis physiopathology, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis psychology, Cross-Sectional Studies, Female, Health Status, Health Surveys, Humans, Male, Middle Aged, Paris, Predictive Value of Tests, Time Factors, Absenteeism, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis diagnosis, Cost of Illness, Employment, Occupational Health, Quality of Life, Sick Leave, Work Capacity Evaluation
Abstract

Objectives: Improved therapeutic strategies for ANCA-associated vasculitis (AAV) have transformed acute and life-threatening diseases into chronic ones responsible for marked morbidity that could impact employment, work disability and quality of life (QoL). We aimed to analyse work, handicaps and QoL of AAV patients and identify their determinants., Methods: Patients with AAV were included in a cross-sectional study assessing employment, work disability and QoL. Specific and non-specific questionnaires, including SF-36, were sent to patients, and clinical-biological data that could affect QoL and their determinants were analysed., Results: Questionnaires were completed by 189 patients. Among 94 working-age (<60 years) patients, 57% had jobs, consistent with their qualifications for 81%, 77% were stably employed; 23% of workers felt that their disease qualitatively limited the nature of their work, while 43% felt it limited the quantity of work they could do; 50% thought their disease had hindered their careers and 43% that it had led to a salary reduction. These results were comparable for the different vasculitides. QoL was significantly impaired for AAV patients compared to the general population (p<0.0001). Physical health determinants for our population were diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA), long disease duration and its neurological involvement, whereas mental health determinants tended to be ear, nose and throat and cardiovascular involvement, and unemployment., Conclusions: Our findings showed that AAV patients' QoL was impaired compared to the general population, mainly for patients with EGPA and long-standing disease. In contrast, normal employment seemed to be preserved for the majority of the patients.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results